BCAL Diagnostics Limited (AU:BDX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BCAL Diagnostics Limited has achieved a significant milestone with the publication of their research in the International Journal of Molecular Sciences, detailing the innovative technology behind their blood test for early-stage breast cancer detection, BREASTEST®. This publication not only reinforces the scientific credibility of their technology but also strengthens BCAL’s position as they move towards commercializing their diagnostic tool in the global market.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.